MX9807083A - Vacuna contra el sindrome reproductivo y respiratorio porcino. - Google Patents

Vacuna contra el sindrome reproductivo y respiratorio porcino.

Info

Publication number
MX9807083A
MX9807083A MX9807083A MX9807083A MX9807083A MX 9807083 A MX9807083 A MX 9807083A MX 9807083 A MX9807083 A MX 9807083A MX 9807083 A MX9807083 A MX 9807083A MX 9807083 A MX9807083 A MX 9807083A
Authority
MX
Mexico
Prior art keywords
vaccine
respiratory syndrome
porcine reproductive
syndrome vaccine
discloses
Prior art date
Application number
MX9807083A
Other languages
English (en)
Other versions
MXPA98007083A (es
Inventor
Richard A Hesse
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24442410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9807083(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9807083A publication Critical patent/MX9807083A/es
Publication of MXPA98007083A publication Critical patent/MXPA98007083A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)

Abstract

La invencion describe una vacuna y métodos para el tratamiento del síndrome reproductivo y respiratorio porcino. La vacuna se obtiene del agente viral NEB-1-P94. Además, la invencion describe un virus de vacuna con características fenotípicas que pude distinguirse del virus de PRRS de tipo cimarron. Deposito en la Asociacion Americana de Cultivos Tipo No. VR-2525.
MXPA/A/1998/007083A 1996-03-01 1998-08-31 Vacuna contra el sindrome reproductivo y respiratorio porcino MXPA98007083A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60980696A 1996-03-01 1996-03-01
US08/609,806 1996-03-01

Publications (2)

Publication Number Publication Date
MX9807083A true MX9807083A (es) 1998-12-31
MXPA98007083A MXPA98007083A (es) 1999-02-01

Family

ID=

Also Published As

Publication number Publication date
RU2187333C2 (ru) 2002-08-20
BG102809A (en) 1999-05-31
KR100297537B1 (ko) 2001-10-26
BR9708443B1 (pt) 2012-06-12
MY115070A (en) 2003-03-31
HUP9901958A3 (en) 2000-04-28
CO4600644A1 (es) 1998-05-08
BG64693B1 (bg) 2005-12-30
EE04741B1 (et) 2006-12-15
HUP9901958A2 (hu) 1999-10-28
JP3135069B2 (ja) 2001-02-13
KR19990087432A (ko) 1999-12-27
WO1997031651A1 (en) 1997-09-04
EP0894007A1 (en) 1999-02-03
CA2248182C (en) 2004-04-20
AU2277497A (en) 1997-09-16
CN1165342C (zh) 2004-09-08
PL328627A1 (en) 1999-02-15
CA2248182A1 (en) 1997-09-04
BR9708443A (pt) 1999-08-03
SK119498A3 (en) 1999-07-12
EE9800267A (et) 1999-02-15
JPH11506122A (ja) 1999-06-02
CZ273798A3 (cs) 1999-02-17
CN1216922A (zh) 1999-05-19
AR006023A1 (es) 1999-07-21
ZA971663B (en) 1997-08-26

Similar Documents

Publication Publication Date Title
CA2248182A1 (en) Porcine reproductive and respiratory syndrome vaccine
HK1016872A1 (en) Viral agent associated with mystery swine disease
HUP9801124A3 (en) New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process
EP0676467A3 (en) European vaccine strains of the porcine reproductive respiratory syndrome virus (PRRSV)
GR3035712T3 (en) European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV)
CA2076744A1 (en) Viral Agent Associated with Mystery Swine Disease
ZA986084B (en) CTL epitopes from EBV
HK1029140A1 (en) Infectious cdna clone or north american porcine reproductive and respiratory syndrome (prrs)virus and uses thereof.
HUT72917A (en) Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines
HK1038507A1 (en) Influenza virus vaccine composition
NO2011024I2 (no) Laksepankreassykdomsvirus (SPDV) stamme F93-125;deponert ved ECACC med deponeringsnummer V94090731 eller nært beslektede stammer med lignende genotypiske og/eller fenotypiske karaktertrekk som den deponerte virusstammen
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
EP1013757A3 (en) Attenuated forms of bovine viral diarrhea virus
NZ331556A (en) Parapoxviruses containing foreign DNA, their production and their use in vaccines
EP0835131A4 (en) DNA CLONE FOR SOUTH AFRICAN ARBOVIRUS No. 86
GB2376687A (en) Herpes viruses for immune modulation
EP0822980A4 (en) RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF
NZ511168A (en) Recombinant CELO virus and CELO virus DNA
EP1074624A4 (en) GENE 62 OF THE ATTENUATED VARICELLA VIRUS STRAIN OKA AND METHOD FOR IDENTIFYING THE VIRUS STRAIN ATTENUATED VARICELLA VACCINE USING THE SAME
樊建中 et al. Assessment of the SiC_p Distribution Uniformity in SiC_p/Al Composites Made by Powder Metallurgy
Chladek et al. Viral agent associated with mystery swine disease
Visser et al. European vaccine strains of the Porcine Reproductive Respiratory Syndrome virus(PRRSV)
Park et al. Pathogenic effects of porcine reproductive and respiratory syndrome virus isolates in swine tracheal ring culture

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status